1. Chugai’s Basic Approach
There are still many people around the world who suffer from diseases that currently have no cure, or even in cases where treatments do exist, are denied access, because of poverty, institutional reasons, etc. The Sustainable Development Goals (SDGs) included in “2030 Agenda for Sustainable Development” adopted by the United Nations in 2015, stipulate “Ensure healthy lives and promote the well-being for all at all ages” as one of its goals. In working toward this goal, Chugai aims to create corporate value and address social issues by creating and supplying new products and cooperating with public institutions, NGOs, industry associations, etc. This in turn will lead to improved access to healthcare, which is an issue of global health.
2. Priorities in Addressing Global Health
2.1 Developing New Products for Diseases with no Treatments
Chugai will create and develop innovative products for unmet medical needs, such as treatments for diseases that currently have no cure, using its drug discovery technology centered on bio-technologies obtained through its research and development.
2.2 Improving Quality of Healthcare and Access to Pharmaceuticals
As its basic approach to improving quality of healthcare, Chugai will work to build the skills of medical staff in terms of prevention, diagnosis and treatment, as well as disseminating healthcare information to people in rural communities.
In addition, it will work towards removing barriers preventing access to pharmaceuticals, including building social infrastructure in low- and middle- income countries.
Through these actions, Chugai will contribute to improving the healthcare system as well as access to pharmaceuticals on a sustainable basis.
3. Points Considered for Individual Activities
Chugai will consider the following points in implementing or supporting individual activities of global health.
- Whether it will utilize Chugai’s strength, technology or specialty
- Whether it will contribute to sustainable improvement of healthcare, mainly in low- and middle- income countries